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Effect of the dialysis membrane on mortality of chronic hemodialysis
patients. Mortality of prevalent chronic hemodialysis patients remains
high. The potential effect of the dialysis membrane on this mortality has
not been previously investigated in a large population of chronic hemo-
dialysis patients. Using data from the United States Renal Data System
(USRDS), we analyzed a random sample of 6,536 patients receiving
hemodialysis on December 31, 1990. The study design was a historical
prospective study. By limiting the study to patients dialyzed for at least one
year with bicarbonate dialysate, in whom the dose of dialysis could be
calculated, and in whom dialysis membrane and co-existing morbidities
were defined, the sample size was reduced to 2,410 patients. A Cox
proportional hazards model was used to estimate relative mortality risk.
The types of dialysis membranes used were broadly classified into three
categories: unsubstituted cellulose, modified cellulose (generally cellulose
membranes that have been modified by substitutions of some or most of
their hydroxyl moieties) and synthetic membranes that are not cellulose-
based. The results of the study suggest that after adjusting for the dose of
dialysis and the presence of co-morbid factors, the relative risk of
mortality of patients dialyzed with modified cellulose or synthetic mem-
branes was at least 25% less than that of patients treated with unsubsti-
toted cellulose membranes (P < 0.001). To account for the possibility that
these differences were due to regional practice patterns, we further
stratified the data for nine different regions. There was still a 20%
difference in relative risk of mortality between membrane groups with the
mortality statistically significantly less in patients treated with synthetic
membranes (P < 0.045) compared to patients dialyzed with unsubstituted
cellulose membranes. The results of this study suggest that the dialysis
membrane plays an important role in the outcome of chronic hemodialysis
patients. However, more definitive studies are needed before a cause and
effect relationship can be proven.
The mortality of hemodialysis patients in the United States has
been high, and in 1992, the mortality of prevalent patients was
approximately 23.2% a year [1]. Recent studies have emphasized
the role of the dose of dialysis, defined by KtIV (K = dialyzer
clearance, t = dialysis time, V = volume of distribution of urea)
or intradialytic urea reduction ratio (defined as 1 minus the ratio
of post-dialysis urea to pre-dialysis urea) in the mortality of
hemodialysis patients. These studies have shown that an increased
dose of delivered dialysis was associated with a lower mortality
rate [2—4]. However, the role of the dialysis membrane in this
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mortality has not been well defined in a large chronic hemodialysis
population.
Although several studies have shown a lower mortality and
hospitalization rates with high-flux biocompatible dialyzers, these
studies compared different patient populations with potentially
different co-morbid conditions or patients dialyzed during differ-
ent periods (non-contemporaneous cohorts) [5—7]. Furthermore,
because high-flux dialyzers typically have higher surface areas and
higher urea clearances than conventional dialyzers, these studies
did not exclude the possibility that the observed improvement in
outcome with these biocompatible high-flux dialyzers could be
due to higher delivered dose of dialysis, or to the use of so-called
volumetric-machines which control precisely the rate of ultrafil-
tration.
The United States Renal Data System (USRDS) was organized
under the auspices of the NIH to analyze data related to kidney
diseases. As part of this activity, the USRDS designed and
implemented the special study of Case-Mix Adequacy with the
Health Care Financing Administration (HCFA) in collaboration
with the End-Stage Renal Disease (ESRD) Networks. This study
was a historical prospective study design and was based on a
random sample of approximately 6,000 prevalent patients receiv-
ing hemodialysis on December 31, 1990. The data were abstracted
and collected by the 18 ESRD Networks. Abstracted data in-
cluded, among other co-variables, the co-morbid factors of pa-
tients, the specific dialyzer used, and the delivered dose of dialysis
calculated from the measured pre- and post-dialysis urea levels
[1]. These data allowed us to analyze the association of specific
dialysis membrane characteristics with the patient mortality rate,
after adjustment for thirteen major comorbid factors such as
patient demographics (age, sex, race), presence or absence of
coronary artery disease, diabetes, pulmonary disease, dose of
dialysis and other factors such as albumin concentration [1].
Methods
Data collection
The survey instrument has been previously published and
includes numerous data items (see for example the USRDS 1995
Annual Data Report). These items include the sex, age, race and
cause of renal failure (diabetes, hypertension, glomerulonephritis
and "other") of the patients, thirteen major co-morbid factors and
specific laboratory values. The impact of each of these factors on
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the relative risk of mortality has been described in the 1995
USRDS annual report [1]. The survey also requested the specific
type of prescribed dialyzers. The composition of the dialysate
(acetate or bicarbonate) was noted as well. The dose of dialysis,
defined by Kt/V in this study, was calculated from the pre- and
post-urea levels, and the pre- and post-dialysis weights of the
patient to adjust for ultrafiltration and urea generation [8].
Patients were selected in a two-stage national sampling plan. A
random sampling of dialysis units was selected, stratified by size.
Following this, random samples of patients were selected within
each unit according to the last two digits of their social security
numbers. The study start date was December 31, 1990 for patients
who were on dialysis before 1990. Patients who started ESRD
therapy during 1990 were excluded from the study. Therefore, the
minimum exposure to dialysis in the study population was at least
one year.
Prior to the start of the statistical analysis, the range of dialysis
membranes used for all patients was classified into three groups:
(1) unsubstituted cellulosic membranes; (2) modified cellulose
membranes which include dialysis membranes such as cellulose
acetate, cellulose diacetate, cellulose triacetate or amino-terminal
substituted (hemophan) membranes; and (3) synthetic mem-
branes which are not cellulose based, and include polysulfone and
polyacrylonitrile membranes (Table 1). In general, dialyzer mem-
branes classified as unsubstituted cellulose membranes were
membranes associated with high complement activation potential
and in vivo ultrafiltration coefficients (defined as the water
flux/mm Hg/hr) of less than 8 to 10 mi/mm Hg/hr, whereas
synthetic membranes were associated with low complement acti-
vation and high ultrafiltration coefficients, generally greater than
20 ml/mm/Hg/hr. Modified cellulose membranes span a wide
range of specifications ranging from the moderate to low comple-
ment activation and low flux of cellulose acetate membranes, to
low complement activation and high water flux (15 mI/mm Hg/hr)
of the cellulose triacetate membranes.
Mortality was estimated using the Cox proportional hazards
model estimated with the PHREG SAS procedure operating on a
Digital Corporation VAX 4300 computer [9]. Time to death (in
days) was modeled from the study start date to the earliest of the
following events: death; transplantation; 60 days after the date of
switch to peritoneal dialysis or the end of the study. The study-end
date was the date of data abstraction which varied from a
minimum of one year to a maximum of three years follow-up.
Mean follow-up of patients was 1.4 years. Study dates were all
taken from record abstraction information from the patients'
medical record.
Sample size
The initial sample size was 6,536 patients, from 523 dialysis
units. To reduce the impact of major comorbidities that result in
early death and the potential effect of residual renal function,
1,729 "incident" patients (less than 1 year following initiation of
dialysis) were excluded. Also, 652 patients dialyzed with acetate
dialysate were excluded because acetate base in the dialysate is
rarely used with high efficiency or high flux dialyzers and are much
more commonly associated with cellulosic dialyzers. Similarly, we
excluded 1,700 patients' records that did not have a pre- and
post-urea measured on the same day, and approximately 45
patients who did not have their dialyzers specified. Thus, the
sample size used for this study was 2,410 patient records.
Table 1. Dialyzer membrane classification
Unsubstituted cellulose Modified cellulose Synthetic
Unsubstituted cellulose Cellulose acetate Polysulfone
Sapon. cellulose Cellulose diacetate Polymethymethecrylate
Cuprophan Cellulose triacetate Polyacrylonitrile
Cupramnonium rayon Hemophan Polyamide
Data are from the USRDS Case Mix Adequacy Study, 1990—91.
Analysis
The Cox proportional hazards model was used to estimate the
effect and statistical significance of all the listed major comorbid
factors, the delivered dose of dialysis and separately the effect of
the dialysis membrane class (unmodified cellulose, modified cel-
lulose and synthetic). In addition, data were stratified for nine
regions in the country to account for potential non-proportional
effects of different geographic practice patterns. In other words, to
be valid, differences that were statistically significant overall also
had to be consistent in the nine regions.
Results
Dialyzers
The proportion of patients dialyzed with unsubstituted cellulose
membrane dialyzers was 65.8%, whereas the proportion of pa-
tients dialyzed with membranes classified as modified cellulose
was 16.1%, and 18.1% of the patients were using membranes
classified as synthetic. The relative fraction of each membrane
within its class is given in Table 1. Other patient and treatment
characteristics are shown in Table 2, grouped by membrane class.
As can be seen, the average number of years on dialysis for
patients dialyzed by different membrane types was approximately
the same (4.5 years), while the number of patients censored
because of transplantation or switch to PD was proportional to the
number of patients included in each membrane class. Of note is
that the average duration of dialysis was considerably shorter in
patients dialyzed with synthetic membranes (172 mm) than in
patients dialyzed with modified or unmodified cellulosic mem-
branes, 191 minutes and 205 minutes, respectively.
Patients dialyzed with unsubstituted cellulose membranes were
defined as the reference group [that is, relative mortality risk
(RR) defined as = 1.01. After an adjustment for all co-morbidities
and patient demographics, but prior to adjustment for the deliv-
ered dose of dialysis defined by Kt/V, the relative risk of mortality
among patients dialyzed with synthetic membranes was 0.72 (P <
0.002), that is, 28% lower risk of death than for patients dialyzed
with the unsubstituted cellulose membrane, used as the reference
group. Patients dialyzed with modified cellulose membranes also
had a relative mortality risk of 0.72 (P <0.002) compared to the
unsubstituted cellulose membrane group. The modified cellulose
and synthetic membrane groups were not significantly different
from each other in their relative mortality risk. These relative
risks, along with their 95% confidence intervals are shown in
Table 3.
The delivered dose of dialysis, calculated from an average of
three measured pre- and post-dialysis measurements of urea and
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Table 2. Characteristics of patients by type of membrane
N pats. Avg. Avg.N censor. dialysis years on Avg. No. Death
pats. for time dialysis at Mean of Kt/V rates TotalN txed switch-PD mm start of study KtIV measured per 100 deaths
Cellulose 1586 92 14 205 4.59 1.07 3.2 23.65 491
Modified cellulose 388 30 5 191 4.28 1.14 2.9 19.17 117
Synthetic 436 34 3 172 4.58 1.14 3.4 17.12 111
All 2410 156 22 196.2 4.53 1.10 3.2 21.56 719
P < 0.01 compared to cellulose group
Table 3. Relative risk of mortality by membrane and modela
Unadjustedb
Model
Adjusted" Stratified
Membrane for Kt/V for Kt/V by region
Cellulose 1.00 (ref) 1.00 (ref) 1.00 (ref)
Modified 0.72' (0.59—0.89) 0.74" (0.60—0.92) O.8O (0.63—1.01)
cellulose
Synthetic 0.72" (0.59—0.88) 075d (0.61—0.73) 0.80 (0.64—0.99)
Numbers in parenthesis represent range of 95% of confidence interval
b After adjustment for all other risk factors and co-morbid conditions
After adjustment for all other risk factors and co-morbid conditions as
well as Kt/V
dp < 0.002
= 0.045
fp = 0.062
weight, were then analyzed by membrane class. As shown in Table
2, the delivered dose of dialysis was slightly higher in the modified
cellulose and synthetic groups (each 1.14 0.01), compared to
the unsubstituted cellulose group (1.07 0.01). This difference
was statistically significant (P < 0.01). Adjusting for delivered
Kt/V, patient demographics and co-morbid factors and excluding
patients without a measured KtIV, the relative risk of mortality of
patients dialyzed with the synthetic membranes was 0.75 (P <
0.002) compared to the unsubstituted cellulose membrane refer-
ence group. Patients dialyzed on modified cellulose membranes
had a relative risk of 0.74 (P < 0.02 compared to unsubstituted
cellulose membranes), which was similar to the findings in the
synthetic group (Table 3). Thus the relative risk of death among
patients dialyzed with these modified cellulose or synthetic mem-
branes was approximately 25% lower than for patients dialyzed
with unsubstituted cellulosic membranes, even after adjusting for
the dose of dialysis. Of interest is that inclusion of the patients
who received dialysis using acetate dialysate (predominantly
patients on cellulosic membranes) would make this difference in
relative risk of mortality even larger, since patients dialyzed with
unsubstituted cellulose membranes and treated with acetate dia-
lysate tended to have an even higher mortality risk (RR 1.10,
P < 0.006) than patients on cellulosic membranes treated with
bicarbonate dialysate [10].
In an effort to ascertain whether these differences in mortality
reflect regional differences such as in general medical practice,
patient risk factors or other co-morbid factors, we further ana-
lyzed these data after stratification for nine major regions of the
U.S. Stratification allowed adjustments for potential differences in
the general mortality rates of patients in different regions and
their possible non-proportional hazards effect. Following stratifi-
cation for regions, and again using unmodified cellulose mem-
branes as a reference group (that is, a relative risk of 1.0),
synthetic membranes had a relative risk of mortality of 0.80 (P
0.045 compared to unsubstituted cellulose membranes), while
modified cellulose membranes also had a relative risk of mortality
of 0.80 (P = 0.062) compared to unsubstituted cellulose mem-
branes (Table 3).
Discussion
There is increasing recognition that the dose of delivered
dialysis has an important impact on the survival of patients on
hemodialysis as well as peritoneal dialysis [2—4, 11]. The results of
this study clearly suggest that the type of membrane used for
hemodialysis is an important factor in the relative risk of mortality
that remains statistically robust even after adjustment for the
presence of 13 major co-morbid factors and selected laboratory
values. More importantly, this difference between the membranes
is still large and statistically significant after adjustment for the
dose of dialysis. This difference in relative risk of mortality among
different types of dialysis membrane holds true even after strati-
fication for regional differences in membrane use and case-mix.
Overall, the relative risk of mortality for synthetic and modified
cellulose membranes is at least 20% lower than that for the typical
unsubstituted cellulose membranes.
It is also important to note that although the estimates of
relative mortality among patients dialyzed with different mem-
branes was adjusted for the dose of dialysis, there is evidence that
in high-flux dialysis, where blood flow is rapid and dialysis time is
relatively short (Table 2), urea rebound is greater [12], and
therefore the calculated dose of dialysis represents an overesti-
mate of the true delivered dose, Since the effect of the membrane
is determined after adjusting for the apparent dose of dialysis, it
is possible that the difference in relative mortality risk between
unsubstituted cellulose and synthetic membranes may be more
prominent if the adjustments for the true dose of dialysis could be
made for all three membranes classes.
Although the difference in outcomes is large and statistically
significant, the specific reason(s) for this difference cannot be
ascertained from this study. This important caveat results from
several characteristics of the study design. In particular, the survey
instruments did not include center specific data, such as informa-
tion on the dialysis machines (such as volumetric control), water
treatment systems, the ratio of nurses to technicians, etc. In
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addition, the study design was not a prospective randomized study
designed to address the issue, but was a post-hoc analysis of data
originally designed to study the impact of the dose of dialysis on
outcome. Thus, although the observations are statistically robust,
the explanation of these observations must remain inferential.
Potential explanations of these observations include differences
in the biocompatibilities of these membrane classes. Several
recent studies compared low flux membranes of different biocom-
patibilities in prospective randomized studies and concluded that
better nutritional parameters and lower infection-related hospi-
talizations are found in patients dialyzed with biocompatible
membranes [13—15]. In addition, several other studies have shown
an association between the biocompatibility characteristics of
dialyzer membrane and the extent of inflammatory response
[16—19]. However, in this study, which ranges across several types
of membranes, the complement activation of the membrane was
co-linear with the water flux (KUF) characteristics of the mem-
brane, and their separate effects cannot be easily ascertained.
Other potential explanation for the results of this study may
also relate to the need for ultrafiltration control devices at high
KUF. Dialysis equipment with precise ultrafiltration control are
needed for dialyzers greater than 8 to 10 ml/mm Hg/hr. Thus,
better achievement of the desired post-dialysis weight and avoid-
ance of intradialytic hypotension through ultrafiltration control
may be an explanation for the observed correlation. Such a
hypothesis assumes that volumetric machines are not used for
dialyzers with KUF < 8 ml/mm Hg/hr. Unfortunately, the survey
did not include questions concerning the dialysis machines, and
therefore, at present, there is no evidence in favor or against this
hypothesis.
Another possible explanation for the effect of the membrane is
based on differences in the clearance of middle molecules.
Synthetic, and to a much lesser extent, modified cellulose mem-
branes have a higher clearance for molecules in the i0 to i0
dalton size. Several studies have identified various middle mole-
cules as having a biological effect on various cellular systems [20].
However, at present there are no well-identified middle molecules
in that range (with the exception of /32m) and there are no studies
which have linked specific middle molecules to mortality.
These two membrane properties (flux and biocompatibility) are
interrelated not only statistically because of the correlation be-
tween KUF and complement activation [19], but also pathophysi-
ologically, since the extent of complement activation by the
alternative pathway system is determined to a large extent by the
level of Factor D, a 24 kDa molecule that is cleared by many high
flux membranes [21]. Therefore, the relationship of the relative
risk of mortality and KUF may be superficially related to the KUF
of the membrane, but pathophysiologically may be related to the
extent of complement activation.
The effect of the reuse method or germicide was not analyzed
as a separate risk factor in this study, since the association of
specific membranes and method of reuse with specific germicides
resulted in too few cases in each category for adequate analysis. In
addition, the separate and variable effects of these reuse methods
on the biocompatibility and water flux of these membranes would
make any interpretation of this association speculative.
In summary, the results of this study suggest a large and
statistically significant dialyzer membrane effect. However, con-
clusions about a cause and effect relationship must remain
tentative. For example, it is possible that synthetic membranes
which have high water fluxes and which need to be used in
conjunction with volumetric machines may be more prevalent in
centers that also have a better water treatment system and a
different staff mix that impacts on patient survival. Such a "center
effect" may be as important as the characteristics of the mem-
brane. However, the survey did not include questions that allow us
to answer these issues with statistical rigor. Thus, more extensive
surveys with large samples are needed before such a causal effect
of membrane and mortality can be proven, and the results of this
study should be used to generate testable hypotheses.
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